Advertisement Corgenix and Battelle partner in biodefense programs - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Corgenix and Battelle partner in biodefense programs

Corgenix Medical, a developer of diagnostic test kits, has announced a collaboration with Battelle, a Columbus, Ohio-based independent R&D organization whose business focus includes national security.

Under the collaboration, Corgenix will work with Battelle on biodefense related projects and programs.

Under the terms of the collaboration agreement, Corgenix will provide biodefense project support to Battelle in several areas, including prototype product development, production scale-up, technology transfer, manufacturing, quality control and regulatory compliance.

Douglass Simpson, president and CEO of Corgenix, said: “We are extremely pleased to collaborate with Battelle in their ongoing biodefense efforts. This is an important aspect of our nation’s defense, and Battelle is clearly in the premier position as a long-time provider of biodefense solutions to government and industry.”